FDA Update: Possible Heart Risks with Clarithromycin; Apadaz Receives FDA Approval Michele B. Kaufman, PharmD, BCGP | March 7, 2018After reviewing a 10-year study, the FDA cautions that prescribing clarithromycin to patients with heart disease increases the risk of heart problems or death…